Preferential down-regulation of phospholipase C-β in Ewing's sarcoma cells transfected with antisense EWS-Fli-1

被引:16
作者
Dohjima, T
Ohno, T
Banno, Y
Nozawa, Y
Wen-Yi, Y
Shimizu, K
机构
[1] Gifu Univ, Sch Med, Dept Orthopaed Surg, Gifu 5008705, Japan
[2] Gifu Univ, Sch Med, Dept Biochem, Gifu 5008705, Japan
关键词
phospholipase C; signal transduction; Ewing's sarcoma; antisense EWS-Fli-1; growth inhibition;
D O I
10.1054/bjoc.1998.0870
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
EWS-Fli-1, a fusion gene found in Ewing's sarcoma and primitive neuro-ectodermal tumour (PNET), encodes a transcriptional activator and promotes cellular transformation. We have made stable Ewing's sarcoma cells expressing antisense EWS-Fli-1 transcripts by transfecting the antisense EWS-Fli-1 expression plasmid. These cells showed partial loss of endogenous EWS-Fli-1 proteins and suppression of the cell growth. To elucidate the molecular mechanisms underlying the growth inhibition, we examined the changes of signal transducing proteins by immunoblot analysis in Ewing's sarcoma cells stably expressing antisense EWS-Fli-1 transcripts. Western blotting of the cell proteins revealed that expressions of phospholipase C beta 2 and beta 3 (PLC beta 2, PLC beta 3), and also protein kinase C alpha and beta (PKC alpha, beta) were significantly reduced by transfecting with antisense EWS-Fli-1. The inositol phosphates production by bradykinin (BK), but not platelet-derived growth factor (PDGF), was suppressed in these cells. These results suggest that the PLC beta 2 and PLC beta 3 may play a role in tumour proliferation in Ewing's sarcoma cells. (C) 2000 Cancer Research Campaign.
引用
收藏
页码:16 / 19
页数:4
相关论文
共 31 条
[11]   EWS/FLI1-induced manic fringe renders NIH 3T3 cells tumorigenic [J].
May, WA ;
Arvand, A ;
Thompson, AD ;
Braun, BS ;
Wright, M ;
Denny, CT .
NATURE GENETICS, 1997, 17 (04) :495-497
[12]   THE EWINGS-SARCOMA EWS/FLI-1 FUSION GENE ENCODES A MORE POTENT TRANSCRIPTIONAL ACTIVATOR AND IS A MORE POWERFUL TRANSFORMING GENE THAN FLI-1 [J].
MAY, WA ;
LESSNICK, SL ;
BRAUN, BS ;
KLEMSZ, M ;
LEWIS, BC ;
LUNSFORD, LB ;
HROMAS, R ;
DENNY, CT .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (12) :7393-7398
[13]   POINT MUTATION IN FGF RECEPTOR ELIMINATES PHOSPHATIDYLINOSITOL HYDROLYSIS WITHOUT AFFECTING MITOGENESIS [J].
MOHAMMADI, M ;
DIONNE, CA ;
LI, W ;
LI, N ;
SPIVAK, T ;
HONEGGER, AM ;
JAYE, M ;
SCHLESSINGER, J .
NATURE, 1992, 358 (6388) :681-684
[14]   ANTISENSE RNA INHIBITS SPLICING OF PRE-MRNA INVITRO [J].
MUNROE, SH .
EMBO JOURNAL, 1988, 7 (08) :2523-2532
[15]   STUDIES AND PERSPECTIVES OF PROTEIN-KINASE-C [J].
NISHIZUKA, Y .
SCIENCE, 1986, 233 (4761) :305-312
[16]  
OHNO T, 1994, ONCOGENE, V9, P3087
[17]  
OHNO T, 1993, CANCER RES, V53, P5859
[18]  
OUCHIDA M, 1995, ONCOGENE, V11, P1049
[19]   POINT MUTATION OF AN FGF RECEPTOR ABOLISHES PHOSPHATIDYLINOSITOL TURNOVER AND CA2+ FLUX BUT NOT MITOGENESIS [J].
PETERS, KG ;
MARIE, J ;
WILSON, E ;
IVES, HE ;
ESCOBEDO, J ;
DELROSARIO, M ;
MIRDA, D ;
WILLIAMS, LT .
NATURE, 1992, 358 (6388) :678-681
[20]   CHROMOSOMAL TRANSLOCATIONS IN HUMAN CANCER [J].
RABBITTS, TH .
NATURE, 1994, 372 (6502) :143-149